PRIMATENE is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Wyeth Consumer Healthcare Llc. The primary component is Ephedrine Hydrochloride; Guaifenesin.
| Product ID | 0573-2952_4c359434-9f46-45c6-93c6-15091629ee07 |
| NDC | 0573-2952 |
| Product Type | Human Otc Drug |
| Proprietary Name | PRIMATENE |
| Generic Name | Ephedrine Hcl, Guaifenesin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-01-06 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Wyeth Consumer Healthcare LLC |
| Substance Name | EPHEDRINE HYDROCHLORIDE; GUAIFENESIN |
| Active Ingredient Strength | 13 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2004-01-06 |
| Marketing End Date | 2023-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2004-01-06 |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2004-01-06 |
| Ingredient | Strength |
|---|---|
| EPHEDRINE HYDROCHLORIDE | 12.5 mg/1 |
| SPL SET ID: | 9005482c-25ae-d365-33d1-29269532c74d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0573-2952 | PRIMATENE | ephedrine HCl, guaifenesin |
| 80070-600 | Primatene | EPHEDRINE HYDROCHLORIDE |
| 0363-2529 | Bronchial Asthma Relief | Ephedrine HCl, Guaifenesin |
| 0363-7430 | Bronchial Asthma Relief | Ephedrine HCl, Guaifenesin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRIMATENE 88202829 5841251 Live/Registered |
ARMSTRONG PHARMACEUTICALS, INC. 2018-11-21 |
![]() PRIMATENE 71670640 0608592 Live/Registered |
WHITEHALL PHARMACAL COMPANY 1954-07-26 |